Welcome to the resource library, where you can find strategy, research and examples of promising practice in medicine, commissioning and drug services for hepatitis C
Resources
Showing 301 to 310 of 356 resources
-
Hep C: You Need to Know
This guide provides information on hepatitis c, including the symptoms, testing, treatment and available support in the UK.UK 2013 Other PDF -
HCV Action Shared Practice Case Study, Nottingham: Treatment of HCV infected patients attending a primary care shared care substance misuse clinic with pegylated interferon and ribavirinThis document provides a case study of a nurse-led secondary care HCV treatment clinic which was set up in 2005 within a primary care drug treatment clinic in order to improve access to treatment for a group of disadvantaged HCV patients. It details the programme's key processes, outputs, outcomes and learning points for the future.East Midlands Jan 2013 Case study MS Word
-
Hepatitis B and C: ways to promote and offer testing. Practice-based implementation advice for commissioners, service leads and others providing training for professionals
This implementation advice accompanies the NICE public health guidance (available online at: www.nice.org.uk/guidance/PH43). It draws from the learning and experience of others to provide support for users who may wish to develop an action plan to implement certain aspects of the guidance. It is not NICE guidance. Professionals responsible for implementing the recommendations in the guidance may find this document useful. This document includes example pathways and signposts to resources from other organisations that may help.England Dec 2012 Reports & Research, Strategy & Planning MS Word -
NICE public health guidance 43: Hepatitis B and C - ways to promote and offer testing to people at increased risk of infection
This guidance for commissioners and providers of public services aims to ensure more people at increased risk of hepatitis B and C infection are tested. The recommendations cover awareness-raising; testing; contact tracing; providing and auditing neonatal hepatitis B vaccination; commissioning hepatitis B and C testing and treatment services; and laboratory services for hepatitis B and C testing. This guidance, produced in 2012, was last modified in March 2013.UK Dec 2012 Tools & Templates, Strategy & Planning PDF -
Hepatitis C Testing and Treatment in Wirral. Increasing Treatment Places: A Practical Solution
The following report describes the practical steps taken by the local partnership in Wirral in the wake of the Department of Health’s 2002 publication of the ‘Hepatitis C Strategy for England: Getting Ahead of the Curve’, aimed at systematically increasing hepatitis C awareness and testing in Wirral in such a way as to increase demand for treatment places. In doing so, the partnership hoped to tangibly reduce local hepatitis C prevalence and the associated burden of treatment in the longer term.North West Oct 2012 Reports & Research PDF -
Burden of Liver Disease and Inequalities in the North West of England
This report presents data on liver disease in the North West of England, describing the burden by age, sex, deprivation and geography. It explores routinely available data for the main causes of liver disease; alcohol, hepatitis B and C and fatty liver disease. It is a useful resource for Directors of Public Health, health and wellbeing boards, commissioners and providers of services and others involved in liver disease.North West Sep 2012 Reports & Research PDF -
Increasing hepatitis B and C testing in the prison setting: The use of new diagnostics at HMP Manchester
Hepatitis B and C pose a major challenge to public health in the UK. Up to half a million people have one or both of these viruses, which can cause liver failure and cancer, yet only a minority have been diagnosed. Prevalence is particularly high in the prison population; evenNorth West Sep 2012 Case study, Reports & Research, Strategy & Planning PDF -
Recommendations for the Identification of Chronic Hepatitis C Virus Infection Among Persons Born During 1945–1965
Hepatitis C virus (HCV) is an increasing cause of morbidity and mortality in the United States. Many of the 2.7–3.9 million persons living with HCV infection are unaware they are infected and do not receive care (e.g., education, counseling, and medical monitoring) and treatment. CDC estimates that although persons born during 1945–1965 comprise an estimated 27% of the population, they account for approximately three fourths of all HCV infections in the United States, 73% of HCV-associatedRest of World 17 Aug 2012 Reports & Research PDF -
Hepatitis C in the UK - 2012 Report
The most recent national estimates in 2012 suggested that around 216,000 individuals were chronically infected with hepatitis C (HCV) in the UK. Both hospital admissions and deaths from HCV-related end stage liver disease (ESLD) and hepatocellular carcinoma (HCC) are continuing to rise. In England, statistical modelling predicts that 15,840 individuals will be living with HCV-related cirrhosis or HCC in England in 2020 if left untreated.UK Jul 2012 Reports & Research PDF -
National survey of hepatitis C services in prisons in England, July 2012
This is the first dedicated survey of hepatitis C services in prisons in England. The survey aim was to collect basic information on what type of services are provided in prisons for the diagnosis, treatment and follow-up of prisoners infected by hepatitis C.England Jul 2012 Reports & Research PDF